The problem with prior authorization is not the paperwork, but the judgment call it requires while balancing the rules. The rules are complex, the clinical context is fragmented, the timelines are unforgiving, and the consequences of getting it wrong run in both directions: approve too liberally and you absorb costs you should not; deny without adequate documentation and you face appeals, grievances, and now public reporting scrutiny under CMS-0057-F. Galaxy’s utilization management solution is built specifically to solve this problem, automating the end-to-end prior authorization lifecycle from intake to decision to communication.
Legacy automation tools were built to handle the paperwork. They digitized forms, routed requests through portals, and replaced fax machines with electronic submissions. That was meaningful progress. But the core bottleneck, clinical review and decision logic, remained a human-dependent process. The key is to address it at both ends.
What Legacy Automation Actually Does
It is worth being precise about what rule-based automation can and cannot do. A workflow engine can route an incoming PA request to the appropriate clinical team, verify that required fields are populated, confirm eligibility, and send status updates. These are real efficiency gains. According to the 2024 CAQH Index, only 35% of medical prior authorizations are conducted fully electronically. That means most of the administrative friction in PA still involves phone calls, portals, faxes, and manual review.
The 65% that remains manual has to do with reasoning. Clinical documentation needs to be interpreted, not just received. Criteria need to be applied against a patient's full longitudinal record, not just the fields on a submitted form. Denials need a rationale that can withstand scrutiny. Rules-based systems cannot do any of that. They can only check a box. They cannot think.
The CMS-0057-F Forcing Function
The regulatory environment has sharpened this distinction considerably. Under CMS-0057-F, impacted payers are required to send prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard requests. These are hard deadlines that took effect January 1, 2026, and apply to Medicare Advantage organizations, Medicaid and CHIP managed care plans, Medicaid FFS programs, CHIP managed care entities, and state CHIP FFS programs.
The same rule requires payers to provide a specific reason for every denied PA decision. Those metrics are now subject to public annual reporting, covering approval rates, denial rates, average decision times, and percent of requests approved after appeal. The first reporting deadline passed on March 31, 2026, and the obligation recurs annually. Health plans that cannot generate that data accurately are not just operationally exposed. They are reputationally exposed.
Then comes January 1, 2027: the FHIR API mandate. By that date, impacted payers must implement FHIR-based APIs to support real-time data sharing of prior authorization requests between providers and health plans. The infrastructure required to meet that mandate is not something built in the final quarter before a deadline. It is being built, or not being built, right now.
Legacy automation does not prepare you for any of this. It optimizes the administrative wrapping around a decision. Agentic AI is built to make the decision, or at a minimum, to prepare it so thoroughly that clinical review time drops from hours to minutes.
What Agentic AI Actually Does Differently
The distinction is architectural. Rule-based systems follow predetermined logic trees: if X, then Y. They are brittle when inputs vary, which, in clinical contexts, they always do. Agentic AI reasons. It reads clinical documentation, pulls relevant history from a unified patient record, applies coverage criteria, identifies documentation gaps, and generates a decision recommendation complete with the specific rationale CMS now requires payers to document.
This matters enormously for the payer side of the equation. According to the 2024 CAQH Index, each manual prior authorization transaction costs approximately $3.41 per transaction on the payer side, compared to $0.05 for a fully electronic transaction. At any meaningful volume, that gap is not a rounding error. It is a structural cost problem that compounds with every manual denial review, every appeal cycle, and every resubmission triggered by incomplete documentation on the initial request.
The more durable cost is not transactional. It is the cost of decisions made without a complete clinical context: inappropriate denials that generate appeals and grievances, inappropriate approvals that drive up medical loss ratios, and delayed decisions that erode provider relationships and member satisfaction simultaneously.
Galaxy UM: Agentic AI Across the Full Lifecycle
Galaxy UM is Innovaccer's utilization management solution, built for health plans that need to automate prior authorization without sacrificing clinical rigor. The platform receives requests across multiple channels, uses advanced optical character recognition and natural language processing to extract and structure clinical data from unstructured documents, evaluates medical necessity against payer-specific policies, structures diagnoses, codes, and clinical findings directly into the case record, and communicates decisions to providers in real time, all on a single workflow.
A defining design principle sets Galaxy UM apart from rule-based automation tools: an "only auto-approve, never auto-deny" approach. Any case that does not meet clear approval criteria is routed to a qualified clinician for review, rather than being auto-denied. This keeps humans in the loop where it matters, reduces the risk of inappropriate denials, and produces the kind of documented, defensible decision record that CMS-0057-F public reporting now demands.
The platform draws on unified clinical, claims, and operational data to surface a complete longitudinal picture of each member before a decision is made. Galaxy UM also provides automated turnaround tracking, comprehensive audit trails, and reporting capabilities designed to keep health plans compliant with mandated timelines. As CEO Abhinav Shashank put it: "Utilization management should enable better care, not delay it."
The 2025 CAQH Index, incorporating data from 600 provider organizations and health plans representing 63% of all insured lives, found that electronic prior authorization adoption reached 40% in 2024, up from 31% in 2023. Progress, but still the majority of PA volume runs through processes that cannot meet the speed, documentation, or transparency requirements federal mandate now demands.
Health plans treating prior authorization as an administrative function to be managed will find the next 18 months increasingly difficult. Those treating it as a clinical reasoning problem to be solved with the right AI infrastructure are positioned to hit 72-hour decisions consistently, produce defensible denial documentation at scale, and enter 2027's FHIR API requirements with working systems rather than emergency build timelines.
The difference between legacy automation and agentic AI is not incremental. One optimizes paperwork. The other automates judgment. In the current regulatory environment, only one of those is sufficient.